Linezolid for therapy of
Adult
Anti-Bacterial Agents
/ therapeutic use
Cross Infection
/ drug therapy
Female
Humans
Linezolid
/ therapeutic use
Male
Meningitis, Bacterial
/ drug therapy
Methicillin-Resistant Staphylococcus aureus
Middle Aged
Retrospective Studies
Spain
Staphylococcal Infections
/ drug therapy
Staphylococcus aureus
Staphylococcus aureus
Linezolid
meningitis
methicillin-resistant
Journal
Infectious diseases (London, England)
ISSN: 2374-4243
Titre abrégé: Infect Dis (Lond)
Pays: England
ID NLM: 101650235
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
pubmed:
11
7
2020
medline:
22
4
2021
entrez:
11
7
2020
Statut:
ppublish
Résumé
Linezolid has good penetration to the meninges and could be an alternative for treatment of Retrospective multicenter cohort study of 26 adults treated with linezolid, derived from a cohort of 350 cases of There were 15 males (58%) and mean age was 47.3 years. Meningitis was postoperative in 21 (81%) patients. The infection was nosocomial in 23 (88%) cases, and caused by methicillin-resistant Linezolid appears to be effective and safe for therapy of
Sections du résumé
BACKGROUND
Linezolid has good penetration to the meninges and could be an alternative for treatment of
METHODS
Retrospective multicenter cohort study of 26 adults treated with linezolid, derived from a cohort of 350 cases of
RESULTS
There were 15 males (58%) and mean age was 47.3 years. Meningitis was postoperative in 21 (81%) patients. The infection was nosocomial in 23 (88%) cases, and caused by methicillin-resistant
CONCLUSIONS
Linezolid appears to be effective and safe for therapy of
Identifiants
pubmed: 32648796
doi: 10.1080/23744235.2020.1789212
doi:
Substances chimiques
Anti-Bacterial Agents
0
Linezolid
ISQ9I6J12J
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM